Seizure-relapse risk following antiseizure medication withdrawal in children with non-lesional focal epilepsy
Epilepsy & Behavior · 2025
DOI: 10.1016/j.yebeh.2025.110439 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsy & Behavior, 2025. Verfasst von Hideaki Kanemura und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Toho University Medical Center Sakura Hospital, 564-1 Shimoshizu, Sakura, Chiba 285-8741, Japan; Department of Pediatrics, …. Hauptthemen laut MEDLINE: Anticonvulsants, Epilepsies, Partial, Seizures. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
AIMS: We investigated seizure-relapse risk following antiseizure medication (ASM) withdrawal in children with focal epilepsy (FE) who were leading to seizure remission by ASM monotherapy without drug replacement. METHODS: Participants were treated at our hospital between 1 July 1999 and 30 June 2015. Children showing abnormalities on brain MRI and self-limited FE were excluded. All children discontinued ASMs after more than 2 years of a seizure-free state. Associations between seizure relapse within 2 years following ASM withdrawal and age at onset, seizure-free interval before ASM withdrawal, duration of tapering, presence of interictal epileptiform discharges (IEDs) on electroencephalogram (EEG), and type of ASM used were evaluated. RESULTS: Participants comprised 128 FE children. Twelve children (9.7 %) experienced seizure relapse. Ages at both onset and ASM withdrawal were significantly higher in the relapse group than in the non-relapse group (p < 0.0001 and p = 0.0003, respectively). Seizure-free interval before ASM withdrawal was significantly shorter in the relapse (mean, 2.6 years) than in the non-relapse group (3.6 years; p < 0.0001). Duration of tapering was significantly shorter in the relapse (mean, 5.3 months) than in the non-relapse group (9.2 months; p < 0.0001). Presence of IEDs was significantly more frequent in the relapse than in the non-relapse group (p = 0.03). Seizure relapse tended to be less frequent with levetiracetam treatment than with carbamazepine, but the difference was not significant (p = 0.067). CONCLUSIONS: Among FE children who achieve a seizure-free state on ASMs for more than 3 years, clinicians should recommend withdrawal of ASM using a slow tapering schedules lasting more than 6 months.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Toho University Medical Center Sakura Hospital, 564-1 Shimoshizu, Sakura, Chiba 285-8741, Japan; Department of Pediatrics, Faculty of Medicine, University of Yamanashi, 1110 Chuo, Yamanashi 409…
- Department of Pediatrics, Toho University Medical Center Sakura Hospital, 564-1 Shimoshizu, Sakura, Chiba 285-8741, Japan. Electronic address: yoshihiro.miyasato@med.toho-u.ac.jp.
- Department of Pediatrics, Toho University Medical Center Sakura Hospital, 564-1 Shimoshizu, Sakura, Chiba 285-8741, Japan. Electronic address: yutaro.tomi@med.toho-u.ac.jp.
- Department of Pediatrics, Faculty of Medicine, University of Yamanashi, 1110 Chuo, Yamanashi 409-3898, Japan. Electronic address: fsano@yamanashi.ac.jp.
Zitieren
APA
Kanemura, H., Miyasato, Y., Tomi, Y., & Sano, F. (2025). Seizure-relapse risk following antiseizure medication withdrawal in children with non-lesional focal epilepsy. Epilepsy & Behavior. https://doi.org/10.1016/j.yebeh.2025.110439
Vancouver
Kanemura H, Miyasato Y, Tomi Y, Sano F. Seizure-relapse risk following antiseizure medication withdrawal in children with non-lesional focal epilepsy. Epilepsy & Behavior. 2025. doi:10.1016/j.yebeh.2025.110439
BibTeX
@article{Kanemura2025,
author = {Kanemura, Hideaki and Miyasato, Yoshihiro and Tomi, Yutaro and Sano, Fumikazu},
title = {Seizure-relapse risk following antiseizure medication withdrawal in children with non-lesional focal epilepsy},
journal = {Epilepsy & Behavior},
year = {2025},
doi = {10.1016/j.yebeh.2025.110439}
}
EUVIMED